OSSIO, Inc., a fast-growing medical device company focused on evolving orthopedic surgery with bio-integrative fixation technology, recently closed on $27.6 million in equity funding to rapidly scale all aspects of its commercial efforts, including a new product pipeline, sales channel and medical education, as well as building out a flagship U.S. manufacturing site and surgeon training center in Florida.

Read more here.